# US 2012/0253258 A1 · Ocular system with anchoring implant and therapeutic agent

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253258 A1
- Document ID: US20120253258A1
- Status: Published application
- Kind: A1
- Application number: 13/399,760
- Filed: 2012-02-17
- Published: 2012-10-04
- Earliest claimed: 2001-04-07
- Assignees: Dose Medical Corporation
- Inventors: Hosheng Tu; Jason Artof; David Haffner
- Web page: https://patentgrep.com/patent/US20120253258A1

## CPC

- A61F 9/00781: {Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002)}
- A61F 9/0017: {implantable in, or in contact with, the eye, e.g. ocular inserts}
- A61K 31/215: of carboxylic acids
- A61F 2220/0008: Fixation appliances for connecting prostheses to the body
- A61F 2230/0069: cylindrical
- A61F 2250/0067: Means for introducing or releasing pharmaceutical products into the body
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Ocular implants, delivery devices and methods for treating ocular disorders are disclosed. One method involves inserting an implant on one side of an eye. The implant has an anchor on a distal end portion and an outlet opening that is disposed proximal of the anchor. The implant is advanced across the eye to the other side of the eye. The anchor is inserted into eye tissue on the other side of the eye. A therapeutic agent is eluted using the implant.

## Claims

### Claim at position 1

-20. (canceled)

### Claim 21

A system for treating an ocular disorder, comprising:
an implant comprising an anchor on a distal end portion of the implant and an outlet opening disposed proximal of the anchor;
a therapeutic agent; and
a delivery device comprising an elongate body and configured to insert the implant on one side of an eye, advance the implant across the eye to an other side of the eye, and insert the anchor into eye tissue on the other side of the eye.

### Claim 22 (depends on 21)

The system of claim 21, wherein the therapeutic agent is part of the implant.

### Claim 23 (depends on 22)

The system of claim 22, wherein the implant has a body and the therapeutic agent is part of the body of the implant.

### Claim 24 (depends on 21)

The system of claim 21, wherein the therapeutic agent is appended to the implant.

### Claim 25 (depends on 21)

The system of claim 21, wherein the therapeutic agent is coated on a surface of the implant.

### Claim 26 (depends on 21)

The system of claim 21, wherein at least a portion of the implant is configured to elute the therapeutic agent into the eye.

### Claim 27 (depends on 21)

The system of claim 21, wherein the implant is configured to deliver the therapeutic agent through the outlet opening.

### Claim 28 (depends on 21)

The system of claim 21, wherein a portion of the delivery device is configured to transport the therapeutic agent into the eye.

### Claim 29 (depends on 21)

The system of claim 21, wherein the implant comprises a controller to control fluid flow through the implant.

### Claim 30 (depends on 21)

The system of claim 21, wherein the controller comprises a valve.

### Claim 31 (depends on 21)

The system of claim 21, wherein the anchor comprises a structure selected from the group consisting of a conical shape, a screw, at least one protrusion, and a circumferential indentation.

### Claim 32 (depends on 21)

The system of claim 21, wherein the anchor comprises a sharp end.

### Claim 33 (depends on 32)

The system of claim 32, wherein the sharp end of the anchor is at a distal-most end of the distal end portion.

### Claim 34 (depends on 21)

The system of claim 21, wherein the implant comprises at least one inlet opening in fluid communication with at least the outlet opening.

### Claim 35 (depends on 21)

The system of claim 21, wherein the anchor is configured to be embedded in scleral tissue such that the anchor only partially penetrates the sclera.

### Claim 36 (depends on 21)

The system of claim 21, wherein the implant is configured such that on implantation in the eye at least a portion of the implant is in contact with a choroid of the eye.

### Claim 37 (depends on 21)

The system of claim 21, wherein the delivery device is configured to advance the implant across an anterior chamber of the eye.

### Claim 38 (depends on 21)

The system of claim 21, wherein the system is configured so that the therapeutic agent is released into a location adjacent to a choroid of the eye.

### Claim 39 (depends on 21)

The system of claim 21, wherein the system is configured to drain aqueous humor from an anterior chamber of the eye through the implant toward a choroid of the eye.

### Claim 40 (depends on 21)

The system of claim 21, wherein the delivery device is configured to access an anterior chamber of the eye and introduce the implant into the anterior chamber through the incision.
